Programme

Thursday, October 1

8:00-9:00 Registration and coffee
9:00-9:05 Symposium opening words: Päivi Ojala
9:05-9:15 Awarding of the Eero Saksela Prize
9:15-9:45 Special lecture: FCI 40 years Pirkko-Liisa Kellokumpu-Lehtinen, University of Tampere, Finland
9:45-10:30 Keynote: Leveraging Metabolism to Cure Primary and Metastatic Kidney Cancer, Celeste Simon, Perelman School of Medicine, University of Pennsylvania, PA, US

10:30-11:00 Coffee, posters and exhibition

Session 1: Liquid Biopsy: Ready For Prime Time?

chairs Matti Nykter and Jussi Nikkola.

11:00-11:30 Utilizing minimal residual disease for guiding therapy, Tenna Vestman Henriksen, University of Aarhus, Denmark
11:30-12:00 Minimal residual disease from data perspective, Sampsa Hautaniemi, University of Helsinki, Finland
12:00-12:30 Utilizing utDNA for bladder cancer diagnostics, Trine Strandgaard, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark and Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
12:30-12:45 Short talk from abstracts

12:45-13:45 Lunch, posters and exhibition

Session 2: Moving From Prognostic To Predictive

Chairs Annika Auranen and Juha Väyrynen.

13:45-14:15 Targeting the DNA damage response: from bench to bedside, Thomas Helleday, Karolinska Institutet, Sweden
14:15-14:45 New precision medicine approaches for patients with high grade ovarian carcinoma, James Brenton, University of Cambridge, UK
14:45-15:00 Short talk from abstracts
15:00-15:15 Short talk from abstracts

15:15-15:45 Coffee, posters and exhibition

Session 3: Molecules In Place: Mapping Biology With Spatial Precision

Chairs Mikael Marttinen and Leena Latonen.

15:45-16:15 Eero Saksela Prize talk
16:15-16:45 Integrating Histopathology, Spatial Biology and AI for Translational Biomarker Discovery in Cancer, Nic Reitsam, Universität Augsburg, Germany
16:45-17:00 Short talk from abstracts
17:00-17:10 Short talk from abstracts

17:10-18:10 Poster session with sparkling wine
19.00 Dinner

Friday, October 2

Session 4: Imaging Across Scales

Chairs Teemu Ihalainen and Pekka Ruusuvuori.

9:00-9:40 TBA
9:40-10:00 TBA, Anniina Färkkilä, University of Helsinki
10:00-10:15 Short talk from abstracts
10:15-10:30 Short talk from abstracts

10:30-11:00 Coffee, posters and exhibition

Session 5: Novel Mechanisms and Therapeutics 

Chairs Anniina Färkkilä and Heidi Haikala.

11:30-12:00 Molecular and therapeutic landscape of clear cell renal carcinoma, Natasha Kyprianou, Icahn School of Medicine, Mount Sinai, NY, US
12:30-13:00 Utilizing precision oncology for drug development, Juha Rantala, Misvik Biology, Turku; Orion Pharma, Turku, Finland
13:00-13:15 Short talk from abstracts

13:15-14:15 Lunch

Session 6: Why Are We Not There, Yet?

Chairs Toni Seppälä and Sauli Vuoti

14:15-14:45 Translational gap in novel diagnostics methods, Juha Kononen, Docrates Mehiläinen
14:45-15:30 Panel discussion
15:30-15:45 Closing words including poster prizes

Speakers